12th Aug 2021 11:27
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 11 August 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
753,251 | 10.7900 GBP | 10.7750 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
172,192 | 10.7900 GBP | 10.7700 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Short
Increase Long
Increase Short
Opening a Long Position
Opening a Short Position | 165 1,362 220 13,512 13,628
35 790 444 1
6,337 1,054 177,634 32,000
116 8,314 8 7,000 1,270
410,610 | 10.7799 GBP 10.7800 GBP 10.7895 GBP 10.7898 GBP 10.7900 GBP
10.7800 GBP 10.7813 GBP 10.7884 GBP 10.7900 GBP
10.7801 GBP 10.7802 GBP 10.7808 GBP 10.7851 GBP
10.7759 GBP 10.7782 GBP 10.7789 GBP 10.7843 GBP 10.7897 GBP
10.7750 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rightsof any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 12 August 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L